Session Chair Profile
Ph.D., Partner, Fenwick & West
Dr. Shuster is a partner in Fenwick & West’s Intellectual Property Practice and is co-chair of the firm’s Life Sciences Group. Dr. Shuster has legal and technical experience representing companies in biotechnology and high technology areas that include protein and nucleic acid chemistry, clean tech, high resolution protein structures, proteomics, genomics, combinatorial peptide libraries, vaccine development for viral and autoimmune disorders, transdermal drug delivery systems, liposomal drug formulations as well as microfluidics devices.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: In this timely session, top intellectual property attorneys will provide an update on patent law pertaining to personalized medicine issues. You will get a give a brief recap of 35 U.S.C. 101 case law developments followed by an update of the most recent guidance from the US Patent Office on Patent Subject Matter Eligibility. You’ll also receive a survey of international considerations and updates in this important area of patent law, highlighting practical implications of developing 101 case law. You will take away insights into how to adapt a patent strategy in light of these new developments.